Evidence map›Paper›PMID 42875959›Full record

ArticleEuropean journal of immunology2026

Discovery of Avian TCRVβ2

Nitin Kamble, Faisal R Anjum, Shahriar Behboudi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nitin KambleThe Pirbright Institute, Pirbright, Woking, UK.
Faisal R AnjumBristol Veterinary School, University of Bristol, Langford, UK.
Shahriar BehboudiThe Pirbright Institute, Pirbright, Woking, UK.

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

This study presents the discovery and first functional characterization of chicken lipid-reactive Natural Killer T (NKT)-like cells, resolving a long-standing knowledge gap in avian immunology. Using purified TCRVβ2

Indexed as

Avian ProteinsChickensGangliosidesG(M3) GangliosideNatural Killer T-CellsReceptors, Antigen, T-Cell, alpha-betaAnimalsAntigen-Presenting Cellsbeta-Galactoside alpha-2,3-SialyltransferaseCoculture TechniquesGlycosphingolipidsInterferon-gammaInterleukin-18Lymphocyte ActivationSialyltransferasesSignal TransductionAvian Proteinsbeta-Galactoside alpha-2,3-SialyltransferaseGangliosidesGlycosphingolipidsG(M3) GangliosideInterferon-gammaInterleukin-18Receptors, Antigen, T-Cell, alpha-betaSialyltransferasesCD1.1gangliosidesNKT cellsT cellsTCR

Identifiers

PMID42875959
PMCPMC13669416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.